Search Results 201-210 of 3306 for Orf
Correction: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD).
Shah A, Molligan JF, Dehner CA, Torres-Mora J. Diagnostic Utility of PRAME in Rare Melanoma Mimics: A Comparative Analysis Including GNET, MMNST, ...
Learn about the experts and services, including awake brain surgery, available for the diagnosis and treatment of brain and central nervous system tumors.
Mayo Clinic cardiovascular specialists translated an established neurovascular therapy into a novel coronary application. This first-time use in the heart ...
About this study. The objective of this study will be to prospectively evaluate the response of a continuous infusion of recombinant human antithrombin ...
About this study. The primary aim of this clinical investigation is to examine a prototype of a quantitative monitoring instrument that will meet most, ...
This is a prospective, randomized, multi-center clinical trial for chronic kidney disease (CKD) patients referred for creation of a new arteriovenous fistula ( ...
The purpose of this trial is to determine the safety and effectiveness of the Edwards SAPIEN XT and the Edwards SAPIEN 3 transcatheter heart valve and delivery ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Publications · Bhatt HV, Fritz AV, Feinman JW, Subramani S, Malhotra AK, Townsley MM, Weiner MM, Sharma A, Choi J, Shmukler J, Bovill Shapiro A, Rivero A, King J ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.